Matthew Feeney

Building the future: Recruiting for foundation models, GenAI and LLMs in biology

Sam Francis, Associate Director at BioTalent, on the skills and talent strategies reshaping foundation model, GenAI and LLM hiring in biology.

Building a more equitable future in health tech with Jiun Kimm

Jiun Kimm on DEI leadership in health tech, the corporatisation of healthcare, and how AI could help tackle disparities in care.

From batch to bioreactor: How Industry 4.0 is reinventing CDMO flexibility

Why flexibility is the new CDMO differentiator, and how digital twins, real-time analytics and AI are reshaping biomanufacturing talent needs.

The impact of Generative AI on life sciences professionals

Nicholas Boyle polled his network on generative AI's day-to-day impact here's what life sciences professionals said.

Transforming maternal health through purpose and leadership with Tracy MacNeal

Tracy MacNeal, CEO of Materna Medical, on making childbirth safer, energy-first leadership, and embedding equity as a performance metric.

Why the seed funding slowdown is a talent problem, not just a funding one.

Seed funding in life sciences is down 44% year on year, and BioTalent explains why that funding gap points to a hiring gap a few years out.

Consultant spotlight: Molly Kennedy, Associate Director

Molly Kennedy, Associate Director at BioTalent, on leading the Pharma Services practice across the US and the trends shaping healthcare communications hiring.

Consultant spotlight: Perrin Joel - Client Solutions Director

Perrin Joel, Client Solutions Director at BioTalent US, on building client partnerships in Digital Health and the AI driven demand for GTM and sales talent.

Workforce Engineering: The Future of Biopharmaceutical Manufacturing

Jason Beckwith's new publication introduces workforce engineering, treating workforce capability as a measurable production asset alongside capital and…

What AI adoption means for your scientific talent pipeline

BioTalent explores what AI adoption really means for scientific hiring, and why developing future talent matters more than debating whether AI will replace…

The real cost of a misaligned hire in biopharma and how to reduce the risk

A look at the true cost of a misaligned senior hire in biopharma, and how an evidence led approach to leadership selection can reduce that risk.

The execution gap: why leadership capability is the most underestimated risk in life sciences

Why leadership capability, not scientific quality, is the most underestimated risk in life sciences and how Talent Science™ and BioX address it.